CD4 and hepatocellular carcinoma: Of those individuals with an HCC, 59.0% (n = 147) were late presenters, with a median (25th–75th percentile) CD4+ T-cell count at diagnosis of 287 (120–466) cells/μL, and 18.1% (n = 45) were diagnosed at stage C (Table 1).